Neurology News

Cognivue, a neuroscience company, announced it will launch a national study to differentiate the effectiveness of its cognitive assessment systems.

CHARLOTTE, N.C. – Research shows that switching to daylight savings time not only causes short-term daytime sleepiness in adolescents, it may be linked to chronic mental health issues, Christina F. Chick, PhD, said at the SLEEP meeting.

Biogen Inc. announced that the FDA has accepted a new drug application for tofersen, an investigational drug to treat superoxide dismutase 1 ALS.

NYU Langone Health has been named the top hospital in the United States for neurology and neurosurgery, according to the latest survey from U.S. News & World Report.

RapidAI has announced FDA clearance for Rapid Hyperdensity, a diagnostic tool that enables physicians to quickly assess the severity of injury in patients with acute conditions, such as traumatic brain injury and brain hemorrhages.

CHARLOTTE, N.C. — Deviation from typical sleep pattern was found to affect daily metacognition in college students, according to a poster presented at the SLEEP meeting.

A majority of stroke survivors received no treatment for depression, with sociodemographic differences driving the persistent treatment gap, according to a study published in Neurology.

CHARLOTTE, N.C. — Study participants with a history of migraine experienced less sleep apnea and hypoxia than those without migraine, according to a poster presented at the SLEEP meeting.

Medesis Pharma has received a grant of 300,000 euros from AFM-Téléthon to fund the first phases of preclinical development of its RNA interference treatment for Huntington’s disease, the company announced.

A novel, thermally regulated mattress and pillow shortened sleep onset latency and improved sleep quality in a small cohort of healthy individuals, researchers reported in the Journal of Sleep Research.